Professor Paul Stewart honoured with CBE for services to medical science
We are delighted to share that our former colleague, Professor Paul Stewart, has been awarded a CBE for his outstanding contributions to medical …
News
New Year Honour for BRC staff
We are thrilled to begin 2025 with the exciting news that Dr Kerrie Davies, our Antimicrobial and Infection Emerging Theme Lead, has been …
Ed Vital appointed professor at Leeds
We are delighted to announce the appointment of Ed Vital as Professor at the University of Leeds. Professor Vital’s ground-breaking work focuses on …
World-first Leeds study advocates proactive care for patients with pacemakers
An internationally groundbreaking study has revealed for the first time the benefits of screening for heart failure and providing specialised care for people with pacemakers.
Leeds BRC Prof Del Galdo gives prestigious State of The Art Lecture to American College of Rheumatology
Our colleague and NIHR Leeds BRC member Professor Francesco Del Galdo recently achieved the prestigious accomplishment of giving the State of the Art …
Building Trust: Article of the Month recognition
We’re thrilled to announce that our article, “Building trust and inclusion with under-served groups: a public involvement project employing a knowledge mobilisation approach,” …
World Antimicrobial Awareness Week: Spotlight on innovative research at NIHR Leeds BRC
Antimicrobials have revolutionised medicine, saving countless lives by treating infections that were once fatal.
Anna Dumitriu appointed artist in residence at Leeds Biomedical Research Centre
In an exciting development bridging science, art, and public engagement, we have appointed internationally acclaimed BioArtist Anna Dumitriu as our new Artist in Residence for the 2023–2028 funding cycle.
Signals from the gut could transform rheumatoid arthritis treatment
Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.
Leeds BRC’s Prof. Del Galdo co-leads new EULAR guidelines for systemic sclerosis treatment
Professor Del Galdo, Workstream 3 lead for Musculoskeletal Disease at Leeds Biomedical Research Centre (BRC), has collaborated with experts across Europe and the Middle East to establish comprehensive, evidence-based guidance for the treatment and management of systemic sclerosis (SSc).